Actively Recruiting

Age: 18Years +
All Genders
ID04185779

COLO-COHORT (Colorectal Cancer Cohort) Study

Led by South Tyneside and Sunderland NHS Foundation Trust · Updated on 2020-10-22

15000

Participants Needed

3

Research Sites

104 weeks

Total Duration

On this page

Sponsors

S

South Tyneside and Sunderland NHS Foundation Trust

Lead Sponsor

N

Newcastle University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying colorectal cancer and colorectal adenomas to identify factors that best predict patients at high risk and to develop a risk prediction model. This observational study is national and multi-centre, focusing on patients undergoing colonoscopy either as part of the Bowel Cancer Screening Programme or due to symptoms. It addresses the limitation that current screening mainly considers age and aims to include other risk factors like smoking, alcohol use, family history, obesity, and gut bacteria composition. Participants will be divided into two groups: one group of 10,000 patients referred for colonoscopy will provide detailed health and lifestyle information, including blood, stool, and saliva samples for various tests. Another group of 10,000 patients from the North of England will consent to be contacted for future research studies, providing some health information for this purpose. The study collects data on colonoscopy results, lifestyle factors, and patient experiences through questionnaires. During the study, patients will undergo measurements such as height, weight, and waist circumference, and complete health and food frequency questionnaires. Researchers will analyze colonoscopy findings, stool microbiome patterns, and biological samples to develop a risk prediction model for colorectal neoplasia. The study also aims to establish a platform of patients willing to participate in future research, with all results and patient consents tracked over a five-year period.

CONDITIONS

Brief Title

COLO-COHORT (Colorectal Cancer Cohort) Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Group A: Aged 30 years or older and able to give informed consent
  • Attending colonoscopy through the Bowel Cancer Screening Programme or standard NHS care
  • Group B (COLO-SPEED): Any patient aged 18 years or older attending colonoscopy and able to give informed consent
  • Group B: Patient from the North of England consenting to future contact for research
Not Eligible

You will not qualify if you...

  • Unable to give informed consent
  • Known polyposis syndrome
  • Previous total colectomy
  • Known colonic stricture limiting complete colonoscopy
  • Attending for planned therapeutic procedure other than polypectomy
  • Attending for assessment or surveillance of known inflammatory bowel disease
  • Currently recruited into an interventional clinical trial for colorectal cancer prevention
  • Not in a centre supported by COLO-SPEED infrastructure (for Group B)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Day of colonoscopy

Participants undergo a colonoscopy and provide health questionnaires and biological samples as part of the diagnostic assessment.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants are followed up for up to 5 years to observe colorectal neoplasia occurrence and stool microbiome patterns.

Follow-up contact for questionnaires and data collection

Trial Site Locations

Total: 3 locations

1

South Tyneside and Sunderland NHS Foundation Trust

South Shields, Tyne and Wear, United Kingdom, NE34 0PL

Actively Recruiting

2

Kettering General Hospitals NHS Foundation Trust

Kettering, United Kingdom, NN16 8UZ

Not Yet Recruiting

3

North Tees and Hartlepool NHS Foundation Trust

Stockton-on-Tees, United Kingdom, TS19 8PE

Actively Recruiting

Loading map...

Research Team

S

Sara Koo

A

Amy Burns

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Multicenter, Placebo-controlled Clinical Study of Berberin...

Colorectal Adenoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here